-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.00-83.8% Downside
Aligos Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Aligos Therapeutics, Inc.?
Aligos Therapeutics, Inc. has been rated by research analysts at Piper Sandler, Jefferies in the past 90 days.